Todd M. DuChene, Chief Legal and Administrative Officer of Core Scientific, Inc./tx (NASDAQ:CORZ), filed a Form 4 on September 16, 2026, disclosing the sale of 10,000 shares of common stock on September 14, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Reporting person: Todd M. DuChene, identified in the filing as Chief Legal and Administrative Officer of Core Scientific, Inc./tx
  • Shares sold: 10,000 shares of common stock disposed of (transaction code S) on September 14, 2026
  • Weighted average sale price: $17.1362 per share, with individual transactions ranging from $16.90 to $17.46, inclusive
  • Direct beneficial ownership after sale: 1,207,896 shares held directly
  • Indirect ownership: An additional 700,000 shares held indirectly through a grantor retained annuity trust (GRAT) of which DuChene is the sole trustee
  • 10b5-1 plan: The sale was made under a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2025

Core Scientific Officer Transaction Details and Ownership Structure

According to the filing, Todd M. DuChene, serving as Chief Legal and Administrative Officer at Core Scientific, Inc./tx, a company listed on NASDAQ under the ticker CORZ, disposed of 10,000 shares of common stock on September 14, 2026. The filing indicates the transaction was carried out under a Rule 10b5-1 trading plan that DuChene adopted on December 5, 2025. The reported weighted average sale price was $17.1362, though the filing notes the shares were sold across multiple transactions at prices ranging from $16.90 to $17.46, inclusive.

The filing discloses that, following the reported transaction, DuChene directly holds 1,207,896 shares of Core Scientific common stock. In addition, he holds 700,000 shares indirectly through a grantor retained annuity trust, of which he is identified as the sole trustee. The filing notes that DuChene undertakes to provide full details regarding the number of shares sold at each individual price within the stated range upon request by the issuer, any security holder, or the SEC staff. No derivative securities transactions were reported in this filing.

Core Scientific, Inc./tx is the issuer named in this Form 4. The filing was signed by Todd DuChene on September 16, 2026, and the box indicating that the transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) was checked on the form.

What Was Disclosed

The Form 4 filed September 16, 2026, reports a sale of 10,000 shares of Core Scientific, Inc./tx common stock by Chief Legal and Administrative Officer Todd M. DuChene on September 14, 2026, at a weighted average price of $17.1362, under a pre-established Rule 10b5-1 plan adopted December 5, 2025.